{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "NOK", "exchange": "LSE", "shortName": "BIOTEC PHARMACON ASA BIOTEC PHA", "longName": "ArcticZymes Technologies ASA", "messageBoardId": "finmb_13529463", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketChangePercent": -1.830296, "regularMarketPrice": 37.1, "marketState": "POSTPOST", "firstTradeDateMilliseconds": 1369119600000, "priceHint": 2, "epsTrailingTwelveMonths": 0.938, "bookValue": 5.635, "fiftyDayAverage": 38.657867, "fiftyDayAverageChange": -1.557869, "fiftyDayAverageChangePercent": -0.040298887, "twoHundredDayAverage": 61.736427, "twoHundredDayAverageChange": -24.636429, "twoHundredDayAverageChangePercent": -0.39905822, "priceToBook": 6.5838504, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.6917, "regularMarketTime": 1683908271, "regularMarketDayHigh": 37.1, "regularMarketDayRange": "37.1 - 37.1", "regularMarketDayLow": 37.1, "regularMarketVolume": 1080, "regularMarketPreviousClose": 37.7917, "bid": 0.0, "ask": 0.0, "fullExchangeName": "LSE", "financialCurrency": "NOK", "regularMarketOpen": 37.1, "averageDailyVolume3Month": 4251, "averageDailyVolume10Day": 3744, "fiftyTwoWeekLowChange": 1.1800003, "fiftyTwoWeekLowChangePercent": 0.03285079, "fiftyTwoWeekRange": "35.92 - 88.7", "fiftyTwoWeekHighChange": -51.6, "fiftyTwoWeekHighChangePercent": -0.5817362, "fiftyTwoWeekLow": 35.92, "fiftyTwoWeekHigh": 88.7, "trailingAnnualDividendRate": 0.0, "trailingPE": 0.39552236, "trailingAnnualDividendYield": 0.0, "symbol": "0DRV.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Sykehusveien 23", "address2": "SIVA Innovation Centre PO Box 6463", "city": "Troms\u00f8", "zip": "9294", "country": "Norway", "phone": "47 77 64 89 00", "website": "https://arcticzymes.com", "industry": "", "sector": "", "longBusinessSummary": "ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Troms\u00f8, Norway.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jethro  Holter", "age": 50, "title": "Chief Exec. Officer", "yearBorn": 1972, "fiscalYear": 2021, "totalPay": {"raw": 2739000, "fmt": "2.74M", "longFmt": "2,739,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Borge  Sorvoll", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2021, "totalPay": {"raw": 1916000, "fmt": "1.92M", "longFmt": "1,916,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Marit Sjo Lorentzen", "age": 54, "title": "VP of Operations", "yearBorn": 1968, "fiscalYear": 2021, "totalPay": {"raw": 1335500, "fmt": "1.34M", "longFmt": "1,335,500"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Darren  Ellis", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Dirk  Hahneiser", "age": 54, "title": "VP of Bus. Devel. & Marketing", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}